
Specific role of cytoplasmic dynein in the mechanism of action of an antitumor molecule, Amblyomin-X
Keywords: BTZ; bortezomib; FDA; Food and Drug Administration; Arf6; ADP-ribosylation factor 6; LR; lipid raft; EE; early endosomes; SE; sorting endosomes; ERC; endocytic recycling compartment; RE; recycling endosome; LE; late endosomes; Rab; Ras superfamily of mono